Heal Capital, EBRD in $10.25m series-A for Infermedica

The round also saw participation from existing investors Karma Ventures, Inovo Venture Partners and Dreamit Ventures.

The new capital brings total funding to date to $15m.

The investment will be used for platform R&D to further enhance patient triage and symptom checking features, as well as clinical decision support analysis.

Previous funding
In June 2019, Karma Ventures led a $3.7m seed round for Infermedica. Dreamit, Müller Medien and Inovo also participated.

Company
Founded in 2012 in Wrocław, Infermedica is an AI-driven multi-language platform that aids patient care and healthcare service delivery. The company operates a B2B model and helps insurance and telemedicine companies, and health systems increase efficiency through digital symptom-checks. Infermedica currently employs around 100 specialists and has 60 B2B clients in 30 countries.

People
Infermedica – Piotr Orzechowski (CEO).
Heal Capital – Christian Weiß (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• CEE
• Technology
• Early-stage
• Poland
• EBRD
• Venture